Aerosol BCG Challenge Trial in Healthy UK Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 7, 2016

Primary Completion Date

May 9, 2019

Study Completion Date

May 9, 2019

Conditions
Tuberculosis
Interventions
BIOLOGICAL

BCG

BCG SSI (Due to a global shortage of BCG SSI, BCG Bulgaria used in Group 2)

OTHER

Saline placebo

Saline placebo

BIOLOGICAL

BCG

BCG Bulgaria (InterVax)

Trial Locations (3)

OX3 7LE

Centre for Clinical Vaccinology and Tropical Medicine , University of Oxford, Oxford

Oxford University Hospitals- John Warin Ward, University of Oxford, Oxford

B15 2TH

NIHR Wellcome Trust Clinical Research Facility, University of Birmingham, Birmingham

All Listed Sponsors
collaborator

University of Birmingham

OTHER

lead

University of Oxford

OTHER

NCT02709278 - Aerosol BCG Challenge Trial in Healthy UK Adults | Biotech Hunter | Biotech Hunter